SYSBIOTECH

Executive Summary

SYSBIOTECH is an Austrian biotechnology company specializing in the design and supply of fermentation and bioprocessing equipment for lab, pilot, and industrial scales. Founded in 2010 and headquartered in Graz, the company offers integrated solutions including fermenters, bioreactors, centrifuges, filtration systems, and CIP/SIP units, primarily serving biologics manufacturing. Its equipment has been utilized in COVID-19 vaccine production, highlighting its relevance in pandemic response. As a private entity with no disclosed funding or valuation, SYSBIOTECH operates in a competitive market with established players. However, its focus on modular and scalable bioprocessing solutions positions it to benefit from the growing demand for biologics manufacturing capacity, particularly in emerging markets and for cell and gene therapies. The company's lack of public financial data and limited online presence suggest a low-profile but potentially steady operation.

Upcoming Catalysts (preview)

• Q4 2026Expansion into Cell and Gene Therapy Market60% success
• Q1 2027Strategic Partnership with Major Pharma40% success
• Q2 2027Launch of Single-Use Bioreactor System50% success